Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells

Tetanus-diphtheria vaccine can prime SARS-CoV-2 cross-reactive T cells

Vaccines containing tetanus-diphtheria antigens have been postulated to induce cross-reactive immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which could protect against coronavirus disease (COVID-19). In this work, we investigated the capacity of Tetanus-diphtheria (Td) va...

Full description

Bibliographic Details
Main Authors: Sara Alonso Fernandez, Hector F. Pelaez-Prestel, Tara Fiyouzi, Marta Gomez-Perosanz, Jesús Reiné, Pedro A. Reche
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-07-01
Series:Frontiers in Immunology
Subjects:
COVID-19
SARS-CoV-2
epitope
T cell cross-reactivity
tetanus-diphtheria toxoid vaccines
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1425374/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1425374/full

Similar Items